Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Immunogenicity and Safety Study of Modified TRC-ID Regimen With A New Chromatographically Purified Vero Cell Rabies Vaccine(SPEEDA/TRCS SPEEDA) and Rabies Immunoglobulin

NCT01137045 is registered in ClinicalTrials.gov with Queen Saovabha Memorial Institute as lead sponsor.

NCT NCT01137045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01137045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Immunogenicity and Safety Study of Modified TRC-ID Regimen With A New Chromatographically Purified Vero Cell Rabies Vaccine(SPEEDA/TRCS SPEEDA) and Rabies Immunoglobulin
Lead sponsor
Queen Saovabha Memorial Institute
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2018
Enrollment
210 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rabies